ParaZero’s DropAir Achieves Life-Saving Breakthrough in Precision Critical Blood Transfusions Delivery with IDF and Israeli Ministry of Defense
ParaZero Technologies (Nasdaq: PRZO) has successfully completed a groundbreaking field trial of its DropAir system for precision delivery of blood transfusions. The trial, conducted with the Israeli Ministry of Defense, Ministry of Health, and IDF, demonstrated the system's capability to safely deliver blood units from 200 meters altitude.
The delivered blood transfusions were verified by Rambam Medical Center doctors to be undamaged and fully suitable for human use. The DropAir system is designed for autonomous aerial delivery of sensitive payloads, including medical supplies, tactical equipment, and humanitarian aid, offering a critical solution for emergency scenarios where conventional delivery methods are not feasible.
ParaZero Technologies (Nasdaq: PRZO) ha portato a termine con successo una prova sperimentale all'avanguardia del suo sistema DropAir per la consegna precisa di trasfusioni di sangue. La sperimentazione, svolta con il Ministero della Difesa israeliano, il Ministero della Salute e le forze armate IDF, ha dimostrato la capacità del sistema di consegnare in sicurezza unità di sangue da un'altezza di 200 metri.
I medici del Rambam Medical Center hanno verificato che le trasfusioni consegnate non presentavano danni ed erano pienamente idonee all'uso umano. Il sistema DropAir è studiato per la consegna aerea autonoma di carichi sensibili, tra cui forniture mediche, equipaggiamento tattico e aiuti umanitari, offrendo una soluzione cruciale per scenari d'emergenza in cui i metodi di consegna convenzionali non sono praticabili.
ParaZero Technologies (Nasdaq: PRZO) ha completado con éxito una prueba de campo pionera de su sistema DropAir para la entrega precisa de transfusiones de sangre. El ensayo, realizado con el Ministerio de Defensa israelí, el Ministerio de Salud y las FDI, demostró la capacidad del sistema para entregar con seguridad unidades de sangre desde 200 metros de altitud.
Los médicos del Rambam Medical Center verificaron que las transfusiones entregadas no estaban dañadas y eran totalmente aptas para uso humano. El sistema DropAir está diseñado para la entrega aérea autónoma de cargas sensibles, incluidas suministros médicos, equipo táctico y ayuda humanitaria, ofreciendo una solución crítica para situaciones de emergencia en las que los métodos de entrega convencionales no son viables.
ParaZero Technologies (Nasdaq: PRZO)는 정밀 혈액 수송을 위한 DropAir 시스템의 획기적 현장 시험을 성공적으로 완료했습니다. 이 시험은 이스라엘 국방부, 보건부 및 IDF와 함께 수행되었으며, 시스템이 고도 200미터에서 혈액 단위를 안전하게 투하할 수 있음을 입증했습니다.
Rambam Medical Center의 의사들은 배송된 수혈용 혈액이 손상되지 않았고 인체 사용에 완전히 적합하다고 확인했습니다. DropAir 시스템은 의료물자, 전술 장비, 인도적 지원 등 민감한 화물을 자율적으로 공중에서 전달하도록 설계되어, 기존의 전달 방식이 불가능한 긴급 상황에서 중요한 해결책을 제공합니다.
ParaZero Technologies (Nasdaq: PRZO) a mené avec succès un essai de terrain innovant de son système DropAir pour la livraison précise de transfusions sanguines. L'essai, réalisé avec le ministère de la Défense israélien, le ministère de la Santé et les FDI, a démontré la capacité du système à livrer en toute sécurité des unités de sang depuis une altitude de 200 mètres.
Les médecins du Rambam Medical Center ont vérifié que les transfusions livrées n'étaient pas endommagées et étaient pleinement adaptées à l'usage humain. Le système DropAir est conçu pour la livraison aérienne autonome de charges sensibles, y compris les fournitures médicales, l'équipement tactique et l'aide humanitaire, offrant une solution cruciale pour les situations d'urgence où les méthodes de livraison conventionnelles ne sont pas envisageables.
ParaZero Technologies (Nasdaq: PRZO) hat erfolgreich einen bahnbrechenden Feldversuch seines DropAir-Systems zur präzisen Zustellung von Bluttransfusionen abgeschlossen. Der Test, der mit dem israelischen Verteidigungsministerium, dem Gesundheitsministerium und den IDF durchgeführt wurde, zeigte die Fähigkeit des Systems, Blutkonserven aus 200 Metern Höhe sicher zu liefern.
Ärzte des Rambam Medical Center bestätigten, dass die gelieferten Transfusionen unbeschädigt und uneingeschränkt für den menschlichen Gebrauch geeignet waren. Das DropAir-System ist für die autonome Luftzustellung sensibler Fracht wie medizinischer Versorgung, taktischer Ausrüstung und humanitärer Hilfsgüter konzipiert und bietet eine entscheidende Lösung für Notfallszenarien, in denen herkömmliche Liefermethoden nicht möglich sind.
- Successful validation of blood transfusion delivery from 200m altitude
- Medical verification confirms delivered blood remains suitable for human use
- Strategic partnerships with Israeli defense and health authorities
- System's versatility for both military and civilian applications
- Limited trial data with only one specific altitude tested
- System currently only validated in controlled testing conditions
Insights
ParaZero's successful DropAir trial with Israeli military validates life-saving blood delivery technology, opening significant defense market opportunities.
ParaZero's joint field trial with Israeli defense and health authorities marks a significant technological validation for its DropAir precision delivery system. The successful drop of blood transfusions from 200 meters that remained undamaged demonstrates a critical capability that addresses a specific battlefield challenge – delivering time-sensitive medical supplies to inaccessible locations.
The trial's involvement of multiple prestigious Israeli institutions – MAFAT (Defense R&D), Ministry of Health, IDF Medical Corps, and Technology & Logistics Directorate – provides substantial credibility. The medical verification from Rambam Medical center that the blood remained suitable for human transfusion confirms the system's precision and reliability for sensitive payloads.
From a defense technology perspective, this achievement creates a dual-path commercialization opportunity. The immediate military applications are evident for special operations, combat search and rescue, and forward medical operations. Concurrently, the humanitarian applications for disaster relief, remote medical outposts, and civilian emergency response represent another substantial market.
The DropAir system's compact design suggests deployment flexibility across various platforms – likely compatible with existing military drones, helicopters, and fixed-wing aircraft. This positions ParaZero to potentially integrate into established defense supply chains rather than requiring dedicated delivery vehicles, accelerating potential adoption and deployment timelines while reducing implementation barriers for military customers.
Kfar Saba, Israel, Sept. 09, 2025 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, today announced the successful completion of a joint field trial of its DropAir system for the precision delivery of blood units.
The trial was conducted in collaboration with MAFAT (the Israeli Ministry of Defense Directorate of Defense R&D), the Israeli Ministry of Health, and the Israel Defense Forces (IDF), including the Medical Corps and Technology & Logistics Directorate (ATAL).
During the trial, blood Transfusions were dropped from an altitude of 200 meters AGL using ParaZero’s DropAir system. Following recovery, the Transfusions were inspected by doctors at the Rambam Medical center and confirmed to be undamaged and fully suitable for transfusion to humans.
“This groundbreaking trial demonstrates the potential of DropAir as a life-saving capability in emergency scenarios,” said Ariel Alon, CEO of ParaZero. “When forces in the field urgently require fresh blood Transfusions but cannot be reached by conventional means, we believe that DropAir could provide a precise, safe, and reliable delivery solution. We are proud to work alongside Israel’s defense and health authorities to validate this critical application and save lives in the future.”
The DropAir system is designed for autonomous and precise aerial delivery of sensitive payloads, such as medical supplies, tactical equipment, and humanitarian aid. With its compact design and proven reliability, DropAir offers unmatched flexibility for both military and civilian missions.
Learn more about DropAir by ParaZero: https://parazero.com/dropair-precision-airdrop-system/
About ParaZero Technologies
ParaZero Technologies Ltd. (Nasdaq: PRZO) is an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry. Founded in 2014 by aviation professionals and drone industry veterans, ParaZero is a recognized leader in advanced drone technologies, supporting commercial, industrial, and governmental operations worldwide. The company’s product portfolio includes SafeAir, an autonomous parachute recovery system designed for aerial safety and regulatory compliance; DefendAir, a counter-UAS net-launching platform for protection against hostile drones in both battlefield and urban environments; and DropAir, a precision aerial delivery system. ParaZero’s mission is to redefine the boundaries of aerial operations with intelligent, mission-ready systems that enhance safety, scalability, and security. For more information, visit https://parazero.com.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act and other securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. Forward-looking statements are not historical facts, and are based upon management’s current expectations, beliefs and projections, many of which, by their nature, are inherently uncertain. Such expectations, beliefs and projections are expressed in good faith. However, there can be no assurance that management’s expectations, beliefs and projections will be achieved, and actual results may differ materially from what is expressed in or indicated by the forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the forward-looking statements. For a more detailed description of the risks and uncertainties affecting the Company, reference is made to the Company’s reports filed from time to time with the Securities and Exchange Commission (“SEC”), including, but not limited to, the risks detailed in the Company’s Annual Report on Form 20-F filed with the SEC on March 21, 2025. Forward-looking statements speak only as of the date the statements are made. The Company assumes no obligation to update forward-looking statements to reflect actual results, subsequent events or circumstances, changes in assumptions or changes in other factors affecting forward-looking information except to the extent required by applicable securities laws. If the Company does update one or more forward-looking statements, no inference should be drawn that the Company will make additional updates with respect thereto or with respect to other forward-looking statements. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. ParaZero is not responsible for the content of third-party websites.
Investor Relations Contact:
Michal Efraty
Investor Relations
michal@efraty.com
ParaZero Technologies Ltd. | 1st HaTachana St.
Kfar Saba, Israel 4453001
P: +972-502753666 | E: contact@parazero.com
FAQ
What is ParaZero's DropAir system and how does it work?
How high can ParaZero's DropAir system deliver blood transfusions?
Who validated the safety of blood transfusions delivered by ParaZero's DropAir?
Which organizations partnered with ParaZero for the DropAir blood delivery trial?
What types of payloads can ParaZero's DropAir system deliver?
